Literature DB >> 9529030

Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden.

F Lewin1, S E Norell, H Johansson, P Gustavsson, J Wennerberg, A Biörklund, L E Rutqvist.   

Abstract

BACKGROUND: This case-referent study was conducted to elucidate the role of selected exogenous agents in the etiology of head and neck cancer. The factors studied were tobacco smoking, alcohol intake, the use of moist oral snuff, dietary factors, occupational exposures, and oral hygiene. In this first report, the authors discuss the impact of tobacco smoking, the use of oral snuff, and alcohol consumption.
METHODS: The study base was approximately 2 million person-years at risk and consisted of Swedish males age 40-79 years living in 2 geographic regions during the years 1988-1990. A total of 605 cases were identified in the base, and 756 controls were selected by stratified random sampling from population registries covering the base.
RESULTS: Among those who were tobacco smokers at the time of the study, the relative risk of head and neck cancer was 6.5% (95% confidence interval, 4.4-9.5%). After cessation of smoking, the risk gradually declined, and no excess risk was found after 20 years. The relative risk associated with alcohol consumption of 50 grams or more per day versus less than 10 grams per day was 5.5% (95% confidence interval, 3.1-9.6%). An almost multiplicative effect was found for tobacco smoking and alcohol consumption.
CONCLUSIONS: Tobacco smoking and alcohol intake had a strong interactive effect on the risk of squamous cell carcinoma of the head and neck. Moderate alcohol intake (10-19 grams per day) had little or no effect among nonsmokers. No increased risk was found for the use of Swedish oral snuff.

Entities:  

Mesh:

Year:  1998        PMID: 9529030     DOI: 10.1002/(sici)1097-0142(19980401)82:7<1367::aid-cncr21>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  75 in total

1.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

3.  Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Authors:  Neil D Gross; Jay O Boyle; Jason D Morrow; Myles K Williams; Chaya S Moskowitz; Kotha Subbaramaiah; Andrew J Dannenberg; Anna J Duffield-Lillico
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

4.  Public health implications of smokeless tobacco use as a harm reduction strategy.

Authors:  David A Savitz; Roger E Meyer; Jason M Tanzer; Sidney S Mirvish; Freddi Lewin
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

5.  Smokeless tobacco brand switching: a means to reduce toxicant exposure?

Authors:  D K Hatsukami; J O Ebbert; A Anderson; H Lin; C Le; S S Hecht
Journal:  Drug Alcohol Depend       Date:  2006-09-20       Impact factor: 4.492

6.  Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.

Authors:  Soya Sisy Sam; Vinod Thomas; K S Reddy; Gopalakrishnan Surianarayanan; Adithan Chandrasekaran
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-10       Impact factor: 4.553

Review 7.  PPARγ in head and neck cancer prevention.

Authors:  Mauricio Burotto; Eva Szabo
Journal:  Oral Oncol       Date:  2014-01-13       Impact factor: 5.337

8.  Race/ethnicity and multiple cancer risk factors among individuals seeking smoking cessation treatment.

Authors:  Darla E Kendzor; Tracy J Costello; Yisheng Li; Jennifer Irvin Vidrine; Carlos A Mazas; Lorraine R Reitzel; Paul M Cinciripini; Ludmila M Cofta-Woerpel; Michael S Businelle; David W Wetter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  The burden of mortality from smoking: comparing Sweden with other countries in the European Union.

Authors:  Brad Rodu; Philip Cole
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Authors:  Helena Furberg; Paul Lichtenstein; Nancy L Pedersen; Laura Thornton; Cynthia M Bulik; Caryn Lerman; Patrick F Sullivan
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.